Literature DB >> 31625043

Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics.

Aishwarya Vijay1, Ravi Gupta2, Patrick Liu1, Sanket S Dhruva3,4, Nilay D Shah5,6, Joseph S Ross7,8,9.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31625043      PMCID： PMC7280368          DOI： 10.1007/s11606-019-05432-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  An improved approach to measuring drug innovation finds steady rates of first-in-class pharmaceuticals, 1987-2011.

Authors:  Michael Lanthier; Kathleen L Miller; Clark Nardinelli; Janet Woodcock
Journal:  Health Aff (Millwood)       Date:  2013-08       Impact factor: 6.301

2.  Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.

Authors:  Atholl Johnston; Roland Asmar; Björn Dahlöf; Kate Hill; David Albert Jones; Jens Jordan; Michael Livingston; Graham Macgregor; Michael Sobanja; Panagiotis Stafylas; Enrico Agabiti Rosei; José Zamorano
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

3.  Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available.

Authors:  Mariana P Socal; Ge Bai; Gerard F Anderson
Journal:  JAMA Intern Med       Date:  2019-06-01       Impact factor: 21.873

4.  Estimation of Potential Savings Through Therapeutic Substitution.

Authors:  Michael E Johansen; Caroline Richardson
Journal:  JAMA Intern Med       Date:  2016-06-01       Impact factor: 21.873

5.  Top 200 Drugs by Worldwide Sales 2016.

Authors:  Gottfried Sedelmeier; Joerg Sedelmeier
Journal:  Chimia (Aarau)       Date:  2017-10-25       Impact factor: 1.509
  5 in total
  3 in total

1.  Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

Authors:  Tianna Zhou; Patrick Liu; Sanket S Dhruva; Nilay D Shah; Reshma Ramachandran; Karina M Berg; Joseph S Ross
Journal:  JAMA Intern Med       Date:  2022-02-01       Impact factor: 44.409

2.  Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available.

Authors:  Stacie B Dusetzina; Juliette Cubanski; Leonce Nshuti; Sarah True; Jack Hoadley; Drew Roberts; Tricia Neuman
Journal:  Health Aff (Millwood)       Date:  2020-08       Impact factor: 9.048

3.  The Ecology of Antihypertensives in the United States, 1997-2017.

Authors:  Michael E Johansen; Joshua D Niforatos; Jeremey B Sussman
Journal:  J Gen Intern Med       Date:  2020-09-23       Impact factor: 5.128
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.